Young and Elderly Type 2 Diabetic Patients Inhaling Insulin with the AERx® Insulin Diabetes Management System: A Pharmacokinetic and Pharmacodynamic Comparison-Reference-Cited by-同舟云学术

Young and Elderly Type 2 Diabetic Patients Inhaling Insulin with the AERx® Insulin Diabetes Management System: A Pharmacokinetic and Pharmacodynamic Comparison

Published:2003-11 Issue:11 Volume:43 Page:1228-1234
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Henry Robert R.,Mudaliar Sunder,Chu Neelima,Kim Dennis,Armstrong Debra,Davis Trent T.,An Bob,Reinhardt Rickey R.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference24 articles.

1. Alternative routes of administration as an approach to improve insulin therapy: update on dermal, oral, nasal and pulmonary insulin delivery;Heinemann;Curr Pharm Des,2001

2. The AERx aerosol delivery system;Schuster;Pharm Res,1997

3. Inhalation delivery systems with compliance and disease management capabilities;Gonda;J Control Release,1998

4. Design and testing of aerosol delivery systems for reproducible clinical performance;Cipolla;J Aerosol Med Deposition Clear Eff Lung,1998

5. Pulmonary insulin administration using the AERx (TM) system: physiological and physicochemical factors influencing insulin effectiveness in healthy fasting subjects;Farr;Diabetes Technol Ther,2000

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Routes of Insulin for Diabetes Treatment;International Journal of Advanced Research in Science, Communication and Technology;2023-03-22

2. Challenges and innovations of drug delivery in older age;Advanced Drug Delivery Reviews;2018-10

3. Pulmonary drug delivery to older people;Advanced Drug Delivery Reviews;2018-10

4. Analysis of the variability of the pharmacokinetics of multiple drugs in young adult and elderly subjects and its implications for acceptable daily exposures and cleaning validation limits;International Journal of Hygiene and Environmental Health;2017-06

5. Views on the Therapeutic Needs of Older Adults;Developing Drug Products in an Aging Society;2016